glp-1 news 2025 october 9 We prescribe GLP-1 meds in our bariatric clinic like The expanding landscape of GLP-1

Orlistat (Alli), Sibutramine (Meridia), and Rimonabant (Acomplia) emerged, but some were banned due to cardiovascular and mental health risks

Despite the hype about weight loss drugs known as GLP-1s, serious questions have remained about their efficacy when patients wean off the drugs

Confirmed ginger's role in supporting digestive comfort across multiple clinical contexts

El uso de agonistas del receptor del pptido similar al glucagn tipo 1 (GLP-1RAs, por sus siglas en ingls), utilizados para tratar la diabetes y la obesidad, podra estar asociado con un amplio espectro de efectos sobre la salud, tanto positivos como un menor riesgo de trastornos cardiometablicos como negativos un mayor riesgo de afecciones gastrointestinales o hipertensin